Women who use the Ortho Evra birth-control patch face twice the risk of developing blood clots than those who take the pill, the patch's manufacturer said late Thursday, citing recent company-funded research.
The finding comes from one of two studies comparing the patch and pill, said Ortho Women's Health & Urology, maker of the once-a-week patch. The Raritan, N.J.-based company is owned by Johnson & Johnson.
The first study found no increased risk of clots while its findings on the risk of stroke or heart attack are still being evaluated. Meanwhile, interim results from the second study suggested a twofold increase in the risk of venous thromboembolic events, or clots in the legs and lungs, in women using the patch, Ortho said.
Full Article by Andrew Bridges
# posted by madthumbs @ 11:23 PM
